ULCERATIVE COLITIS (UC)

Clinical trials for ULCERATIVE COLITIS (UC) explained in plain language.

Never miss a new study

Get alerted when new ULCERATIVE COLITIS (UC) trials appear

Sign up with your email to follow new studies for ULCERATIVE COLITIS (UC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 34 Not yet recruiting 25 Not yet finished but already full! 11 Completed 14 Terminated 1

Experimental UC drug trial halted early – what we know

Disease control Terminated

This early-stage trial tested a new antibody drug (BB-TL1A-VIAL-HLE) in 16 healthy volunteers and people with moderate-to-severe ulcerative colitis. The goal was to check safety and see if it could improve colon inflammation. However, the study was terminated early, so we have li…

Matched conditions: ULCERATIVE COLITIS (UC)

Phase: PHASE1 • Sponsor: Vial Australia Pty Ltd • Aim: Disease control

Last updated Jun 27, 2026 08:12 UTC

ULCERATIVE COLITIS (UC)

Get alerted when new ULCERATIVE COLITIS (UC) trials appear

Experimental UC drug trial halted early – what we know